Secondary Logo

Institutional members access full text with Ovid®

Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function

Jacob, Joseph FRCR; Bartholmai, Brian J. MD; Rajagopalan, Srinivasan PhD; Kokosi, Maria MRCP; Nair, Arjun MD; Karwoski, Ronald PhD; Raghunath, Sushravya M. PhD; Walsh, Simon L.F. MD; Wells, Athol U. MD; Hansell, David M. MD

doi: 10.1097/RTI.0000000000000220
Original Articles
Buy
SDC

Purpose: The aim of the study was to determine whether a novel computed tomography (CT) postprocessing software technique (CALIPER) is superior to visual CT scoring as judged by functional correlations in idiopathic pulmonary fibrosis (IPF).

Materials and Methods: A total of 283 consecutive patients with IPF had CT parenchymal patterns evaluated quantitatively with CALIPER and by visual scoring. These 2 techniques were evaluated against: forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), diffusing capacity for carbon monoxide (DLco), carbon monoxide transfer coefficient (Kco), and a composite physiological index (CPI), with regard to extent of interstitial lung disease (ILD), extent of emphysema, and pulmonary vascular abnormalities.

Results: CALIPER-derived estimates of ILD extent demonstrated stronger univariate correlations than visual scores for most pulmonary function tests (PFTs): (FEV1: CALIPER R2=0.29, visual R2=0.18; FVC: CALIPER R2=0.41, visual R2=0.27; DLco: CALIPER R2=0.31, visual R2=0.35; CPI: CALIPER R2=0.48, visual R2=0.44). Correlations between CT measures of emphysema extent and PFTs were weak and did not differ significantly between CALIPER and visual scoring. Intriguingly, the pulmonary vessel volume provided similar correlations to total ILD extent scored by CALIPER for FVC, DLco, and CPI (FVC: R2=0.45; DLco: R2=0.34; CPI: R2=0.53).

Conclusions: CALIPER was superior to visual scoring as validated by functional correlations with PFTs. The pulmonary vessel volume, a novel CALIPER CT parameter with no visual scoring equivalent, has the potential to be a CT feature in the assessment of patients with IPF and requires further exploration.

Supplemental Digital Content is available in the text.

*Department of Radiology

§Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK

Division of Radiology

Department of Physiology and Biomedical Engineering, Mayo Clinic Rochester, Rochester, MN

Brian J. Bartholmai, Ronald Karwoski, and Srinivasan Rajagopalan have a patent: systems and method for analyzing in vivo tissue volumes using medical imaging data. Licensed to Imbio, LLC. Mayo Clinic has received royalties from Imbio, LCC toward licensing CALIPER. Simon L.F. Walsh receives speaker fees from Boehringer Ingelheim. Athol U. Wells receives advisory and/or speaker fees from Intermune, Boehringer Ingelheim, Gilead, MSD, Roche, Bayer, and Chiesi. David M. Hansell receives consultancy fees from AstraZeneca, Intermune, Boehringer Ingelheim, Sanofi, Glaxo Smith Kline, and Roche and an educational website development subsidy from Intermune. The remaining authors declare no conflicts of interest.

Correspondence to: Joseph Jacob, FRCR, Department of Radiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK (e-mail: akelajacob@gmail.com).

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved